Adipose tissue inflammation in the pathogenesis of type 2 diabetes. (Q38587715)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Adipose tissue inflammation in the pathogenesis of type 2 diabetes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

0 references

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Ayano Kohlgruber

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

publication date

1 November 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

published in

Current diabetes report

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26374569%20AND%20SRC:MED&resulttype=core&format=json

Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Protection from obesity-induced insulin resistance in mice lacking TNF-α function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Immunological complications of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Adipose invariant natural killer T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Immune regulation of metabolic homeostasis in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Neutrophils transiently infiltrate intra-abdominal fat early in the course of high-fat feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Invariant NKT cells and CD1d(+) cells amass in human omentum and are depleted in patients with cancer and obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Adipose tissue invariant NKT cells protect against diet-induced obesity and metabolic disorder through regulatory cytokine production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

TLR4 links innate immunity and fatty acid-induced insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Interplay between the immune system and adipose tissue in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Adipose tissue remodeling and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Inflammation Is Necessary for Long-Term but Not Short-Term High-Fat Diet–Induced Insulin Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Weight loss and lipolysis promote a dynamic immune response in murine adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

CD1: antigen presentation and T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Recognition of a lipid antigen by CD1-restricted alpha beta+ T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Regulatory iNKT cells lack expression of the transcription factor PLZF and control the homeostasis of T(reg) cells and macrophages in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Natural killer T cells in adipose tissue prevent insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Activation of natural killer T cells promotes M2 Macrophage polarization in adipose tissue and improves systemic glucose tolerance via interleukin-4 (IL-4)/STAT6 protein signaling axis in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

A novel function of adipocytes in lipid antigen presentation to iNKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Activation of invariant natural killer T cells by lipid excess promotes tissue inflammation, insulin resistance, and hepatic steatosis in obese mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Mice lacking NKT cells but with a complete complement of CD8+ T-cells are not protected against the metabolic abnormalities of diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Host-gut microbiota metabolic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Cutting edge: IL-25 elicits innate lymphoid type 2 and type II NKT cells that regulate obesity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Altered distribution and increased IL-17 production by mucosal-associated invariant T cells in adult and childhood obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

IL-17 regulates adipogenesis, glucose homeostasis, and obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Treg cells, life history, and diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Antigen- and cytokine-driven accumulation of regulatory T cells in visceral adipose tissue of lean mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

The transcriptional regulators IRF4, BATF and IL-33 orchestrate development and maintenance of adipose tissue-resident regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

The double life of a B-1 cell: self-reactivity selects for protective effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

B-1a lymphocytes attenuate insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Eosinophils: changing perspectives in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Eosinophils and type 2 cytokine signaling in macrophages orchestrate development of functional beige fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

IL-33 activates eosinophils of visceral adipose tissue both directly and via innate lymphoid cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Obesity in C57BL/6J mice is characterized by adipose tissue hypoxia and cytotoxic T-cell infiltration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Overview of orchestration of CD4+ T cell subsets in immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Identification of adipose tissue dendritic cells correlated with obesity-associated insulin-resistance and inducing Th17 responses in mice and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Association between specific adipose tissue CD4+ T-cell populations and insulin resistance in obese individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Normalization of obesity-associated insulin resistance through immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

T cell-derived IL-22 amplifies IL-1β-driven inflammation in human adipose tissue: relevance to obesity and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Genetic deficiency and pharmacological stabilization of mast cells reduce diet-induced obesity and diabetes in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Mast cells and metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Adipose tissue as a dedicated reservoir of functional mast cell progenitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Mast cell stabilization: novel medication for obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Infliximab and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

TNF-α Antagonism with Etanercept Decreases Glucose and Increases the Proportion of High Molecular Weight Adiponectin in Obese Subjects with Features of the Metabolic Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

XOMA 052, an anti-IL-1{beta} monoclonal antibody, improves glucose control and {beta}-cell function in the diet-induced obesity mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Interleukin-1-receptor antagonist in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Effect of anti-IL-1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1β antibody, in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Use of salsalate to target inflammation in the treatment of insulin resistance and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Targeting inflammation in the treatment of type 2 diabetes: time to start

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Inhibition of NF-kappa B by sodium salicylate and aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Salsalate improves glycemia and inflammatory parameters in obese young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Association between plasma monocyte chemoattractant protein-1 concentration and cardiovascular disease mortality in middle-aged diabetic and nondiabetic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and Type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Monocyte chemoattractant protein 1-2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the -2518 A-->G promoter polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

A randomized controlled trial with an anti-CCL2 (anti-monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Dual role of CCR2 during initiation and progression of collagen-induced arthritis: evidence for regulatory activity of CCR2+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Monocyte Chemoattractant Protein 1 (MCP-1) in obesity and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Exercise reduces plasma levels of the chemokines MCP-1 and IL-8 in subjects with the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

An increase in the circulating concentration of monocyte chemoattractant protein-1 elicits systemic insulin resistance irrespective of adipose tissue inflammation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11892-015-0670-X

Adipose Natural Regulatory B Cells Negatively Control Adipose Tissue Inflammation.

21 January 2018

1 reference

12 December 2020

MR1 presents microbial vitamin B metabolites to MAIT cells

1 reference

12 December 2020

Targeting CCR2 or CD18 inhibits experimental in-stent restenosis in primates: inhibitory potential depends on type of injury and leukocytes targeted

1 reference

12 December 2020

PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells

1 reference

12 December 2020

Biologic basis for interleukin-1 in disease

1 reference

12 December 2020

Activated type 2 innate lymphoid cells regulate beige fat biogenesis

1 reference

12 December 2020

On the Treatment of Glycosuria and Diabetes Mellitus with Sodium Salicylate

1 reference

12 December 2020

Recognition of vitamin B metabolites by mucosal-associated invariant T cells

1 reference

12 December 2020

1 reference

12 December 2020